
Chinese General Practice ›› 2025, Vol. 28 ›› Issue (05): 541-547.DOI: 10.12114/j.issn.1007-9572.2024.0011
Special Issue: 神经/行为/心理最新文章合辑; 脑健康最新研究合辑
• Stroke Section • Previous Articles Next Articles
Received:2024-02-10
Revised:2024-04-20
Published:2025-02-15
Online:2024-11-25
Contact:
KUANG Jie
通讯作者:
况杰
作者简介:作者贡献:
况杰提出研究选题方向,负责研究设计,论文审校,对文章整体负责;刘祖婷负责统计分析及论文撰写;徐明欢、杨学智、莫佳丽负责数据处理、统计方法协助;刘星雨、杜慧杰、张慧琴负责数据收集、数据整理;易应萍负责研究可行性分析,文章质量控制;所有作者确认了论文的最终稿。
基金资助:CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0011
| 组别 | 例数 | 性别[例(%)] | 年龄[M(QR),岁] | 年龄[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | <60岁 | ≥60岁 | 否 | 是 | 否 | 是 | |||
| 未复发组 | 916 | 607(66.27) | 309(33.73) | 64.0(15.0) | 332(36.24) | 584(63.76) | 593(64.74) | 323(35.26) | 708(77.29) | 208(22.71) |
| 复发组 | 107 | 79(73.83) | 28(26.17) | 66.0(18.0) | 35(32.71) | 72(67.29) | 69(64.49) | 38(35.51) | 85(79.44) | 22(20.56) |
| Z(χ2)值 | 2.152a | -1.572 | 0.378a | <0.001a | 0.145a | |||||
| P值 | 0.142 | 0.116 | 0.539 | 1.000 | 0.703 | |||||
| 组别 | BMI [M(QR),kg/m2] | 既往脑卒中[例(%)] | 高血压[例(%)] | 糖尿病[例(%)] | 血脂异常[例(%)] | |||||
| 无 | 有 | 无 | 有 | 无 | 有 | 无 | 有 | |||
| 未复发组 | 23.1(3.5) | 714(77.95) | 202(22.05) | 225(24.56) | 691(75.44) | 602(65.72) | 314(34.28) | 751(81.99) | 165(18.01) | |
| 复发组 | 22.9(4.9) | 70(65.42) | 37(34.58) | 28(26.17) | 79(73.83) | 63(58.88) | 44(41.12) | 94(87.85) | 13(12.15) | |
| Z(χ2)值 | -0.627 | 7.712a | 0.060a | 1.862a | 1.902a | |||||
| P值 | 0.531 | 0.005 | 0.806 | 0.195 | 0.168 | |||||
| 组别 | NIHSS评分[例(%)] | L[M(QR),×109/L] | M[M(QR),×109/L] | N[M(QR),×109/L] | SIRI [M(QR)] | |||||
| 0~1分 | 2~4分 | 5~15分 | ||||||||
| 未复发组 | 205(22.38) | 484(52.84) | 227(24.78) | 1.60(0.77) | 0.47(0.23) | 4.33(2.22) | 1.22(1.11) | |||
| 复发组 | 19(17.76) | 50(46.73) | 38(35.51) | 1.59(0.84) | 0.49(0.29) | 4.64(3.48) | 1.36(1.70) | |||
| Z(χ2)值 | 5.880a | -1.121 | -0.995 | -1.467 | -2.039 | |||||
| P值 | 0.053 | 0.262 | 0.320 | 0.142 | 0.041 | |||||
| 组别 | SIRI分组[例(%)] | TC [M(QR),mmol/L] | TG [M(QR),mmol/L] | HDL-C [M(QR),mmol/L] | LDL-C [M(QR),mmol/L] | HbA1c [M(QR),%] | ||||
| Q1亚组 | Q2亚组 | Q3亚组 | Q4亚组 | |||||||
| 未复发组 | 233(25.44) | 231(25.22) | 238(25.98) | 214(23.36) | 4.58(1.37) | 1.39(0.92) | 1.07(0.39) | 2.70(1.07) | 5.70(1.20) | |
| 复发组 | 23(21.50) | 24(22.43) | 18(16.82) | 42(39.25) | 4.51(1.56) | 1.48(0.80) | 0.99(0.45) | 2.60(1.08) | 6.10(2.20) | |
| Z(χ2)值 | 13.773a | -1.144 | -0.940 | -1.747 | -1.223 | -2.360 | ||||
| P值 | 0.003 | 0.253 | 0.347 | 0.081 | 0.221 | 0.018 | ||||
Table 1 Comparison of baseline characteristics between ischemic stroke patients either with a recurrence or not
| 组别 | 例数 | 性别[例(%)] | 年龄[M(QR),岁] | 年龄[例(%)] | 吸烟[例(%)] | 饮酒[例(%)] | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| 男 | 女 | <60岁 | ≥60岁 | 否 | 是 | 否 | 是 | |||
| 未复发组 | 916 | 607(66.27) | 309(33.73) | 64.0(15.0) | 332(36.24) | 584(63.76) | 593(64.74) | 323(35.26) | 708(77.29) | 208(22.71) |
| 复发组 | 107 | 79(73.83) | 28(26.17) | 66.0(18.0) | 35(32.71) | 72(67.29) | 69(64.49) | 38(35.51) | 85(79.44) | 22(20.56) |
| Z(χ2)值 | 2.152a | -1.572 | 0.378a | <0.001a | 0.145a | |||||
| P值 | 0.142 | 0.116 | 0.539 | 1.000 | 0.703 | |||||
| 组别 | BMI [M(QR),kg/m2] | 既往脑卒中[例(%)] | 高血压[例(%)] | 糖尿病[例(%)] | 血脂异常[例(%)] | |||||
| 无 | 有 | 无 | 有 | 无 | 有 | 无 | 有 | |||
| 未复发组 | 23.1(3.5) | 714(77.95) | 202(22.05) | 225(24.56) | 691(75.44) | 602(65.72) | 314(34.28) | 751(81.99) | 165(18.01) | |
| 复发组 | 22.9(4.9) | 70(65.42) | 37(34.58) | 28(26.17) | 79(73.83) | 63(58.88) | 44(41.12) | 94(87.85) | 13(12.15) | |
| Z(χ2)值 | -0.627 | 7.712a | 0.060a | 1.862a | 1.902a | |||||
| P值 | 0.531 | 0.005 | 0.806 | 0.195 | 0.168 | |||||
| 组别 | NIHSS评分[例(%)] | L[M(QR),×109/L] | M[M(QR),×109/L] | N[M(QR),×109/L] | SIRI [M(QR)] | |||||
| 0~1分 | 2~4分 | 5~15分 | ||||||||
| 未复发组 | 205(22.38) | 484(52.84) | 227(24.78) | 1.60(0.77) | 0.47(0.23) | 4.33(2.22) | 1.22(1.11) | |||
| 复发组 | 19(17.76) | 50(46.73) | 38(35.51) | 1.59(0.84) | 0.49(0.29) | 4.64(3.48) | 1.36(1.70) | |||
| Z(χ2)值 | 5.880a | -1.121 | -0.995 | -1.467 | -2.039 | |||||
| P值 | 0.053 | 0.262 | 0.320 | 0.142 | 0.041 | |||||
| 组别 | SIRI分组[例(%)] | TC [M(QR),mmol/L] | TG [M(QR),mmol/L] | HDL-C [M(QR),mmol/L] | LDL-C [M(QR),mmol/L] | HbA1c [M(QR),%] | ||||
| Q1亚组 | Q2亚组 | Q3亚组 | Q4亚组 | |||||||
| 未复发组 | 233(25.44) | 231(25.22) | 238(25.98) | 214(23.36) | 4.58(1.37) | 1.39(0.92) | 1.07(0.39) | 2.70(1.07) | 5.70(1.20) | |
| 复发组 | 23(21.50) | 24(22.43) | 18(16.82) | 42(39.25) | 4.51(1.56) | 1.48(0.80) | 0.99(0.45) | 2.60(1.08) | 6.10(2.20) | |
| Z(χ2)值 | 13.773a | -1.144 | -0.940 | -1.747 | -1.223 | -2.360 | ||||
| P值 | 0.003 | 0.253 | 0.347 | 0.081 | 0.221 | 0.018 | ||||
| 变量 | B | SE | Wald χ2值 | P值 | HR(95%CI) | 变量 | B | SE | Wald χ2值 | P值 | HR(95%CI) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别 | 高血压 | ||||||||||
| 女 | 1.00 | 无 | 1.00 | ||||||||
| 男 | 0.339 | 0.220 | 2.372 | 0.123 | 1.40(0.91~2.16) | 有 | -0.079 | 0.220 | 0.128 | 0.720 | 0.92(0.60~1.42) |
| 年龄 | 糖尿病 | ||||||||||
| <60岁 | 1.00 | 无 | 1.00 | ||||||||
| ≥60岁 | 0.143 | 0.206 | 0.480 | 0.488 | 1.15(0.77~1.73) | 有 | 0.271 | 0.196 | 1.904 | 0.168 | 1.31(0.89~1.93) |
| 吸烟 | 血脂异常 | ||||||||||
| 否 | 1.00 | 无 | 1.00 | ||||||||
| 是 | 0.016 | 0.202 | 0.006 | 0.936 | 1.02(0.68~1.51) | 有 | -0.450 | 0.296 | 2.310 | 0.129 | 0.64(0.36~1.14) |
| 饮酒 | SIRI | 0.056 | 0.022 | 6.398 | 0.011 | 1.06(1.01~1.10) | |||||
| 否 | 1.00 | SIRI | |||||||||
| 是 | -0.124 | 0.239 | 0.268 | 0.605 | 0.88(0.55~1.41) | Q1亚组 | 1.00 | ||||
| 既往脑卒中 | Q2亚组 | 0.043 | 0.292 | 0.022 | 0.883 | 1.04(0.59~1.85) | |||||
| 无 | 1.00 | Q3亚组 | -0.258 | 0.315 | 0.670 | 0.413 | 0.77(0.42~1.43) | ||||
| 有 | 0.590 | 0.203 | 8.439 | 0.004 | 1.81(1.21~2.69) | Q4亚组 | 0.637 | 0.259 | 6.035 | 0.014 | 1.89(1.14~3.15) |
| BMI | -0.006 | 0.033 | 0.039 | 0.844 | 0.99(0.93~1.06) | TC | -0.137 | 0.096 | 2.050 | 0.152 | 0.87(0.72~1.05) |
| NIHSS评分 | TG | 0.108 | 0.065 | 2.816 | 0.093 | 1.12(0.98~1.27) | |||||
| 0~1分 | 1.00 | HDL-C | 0.026 | 0.012 | 4.929 | 0.026 | 1.03(1.00~1.05) | ||||
| 2~4分 | 0.106 | 0.270 | 0.154 | 0.695 | 1.11(0.66~1.89) | LDL-C | -0.185 | 0.119 | 2.441 | 0.118 | 0.83(0.66~1.05) |
| 5~15分 | 0.572 | 0.281 | 4.141 | 0.042 | 1.77(1.02~3.07) | HbA1c | 0.001 | 0.001 | 4.767 | 0.029 | 1.00(1.00~1.00) |
Table 2 Univariate Cox regression analysis on influencing factors for the recurrence of ischemic stroke patients
| 变量 | B | SE | Wald χ2值 | P值 | HR(95%CI) | 变量 | B | SE | Wald χ2值 | P值 | HR(95%CI) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 性别 | 高血压 | ||||||||||
| 女 | 1.00 | 无 | 1.00 | ||||||||
| 男 | 0.339 | 0.220 | 2.372 | 0.123 | 1.40(0.91~2.16) | 有 | -0.079 | 0.220 | 0.128 | 0.720 | 0.92(0.60~1.42) |
| 年龄 | 糖尿病 | ||||||||||
| <60岁 | 1.00 | 无 | 1.00 | ||||||||
| ≥60岁 | 0.143 | 0.206 | 0.480 | 0.488 | 1.15(0.77~1.73) | 有 | 0.271 | 0.196 | 1.904 | 0.168 | 1.31(0.89~1.93) |
| 吸烟 | 血脂异常 | ||||||||||
| 否 | 1.00 | 无 | 1.00 | ||||||||
| 是 | 0.016 | 0.202 | 0.006 | 0.936 | 1.02(0.68~1.51) | 有 | -0.450 | 0.296 | 2.310 | 0.129 | 0.64(0.36~1.14) |
| 饮酒 | SIRI | 0.056 | 0.022 | 6.398 | 0.011 | 1.06(1.01~1.10) | |||||
| 否 | 1.00 | SIRI | |||||||||
| 是 | -0.124 | 0.239 | 0.268 | 0.605 | 0.88(0.55~1.41) | Q1亚组 | 1.00 | ||||
| 既往脑卒中 | Q2亚组 | 0.043 | 0.292 | 0.022 | 0.883 | 1.04(0.59~1.85) | |||||
| 无 | 1.00 | Q3亚组 | -0.258 | 0.315 | 0.670 | 0.413 | 0.77(0.42~1.43) | ||||
| 有 | 0.590 | 0.203 | 8.439 | 0.004 | 1.81(1.21~2.69) | Q4亚组 | 0.637 | 0.259 | 6.035 | 0.014 | 1.89(1.14~3.15) |
| BMI | -0.006 | 0.033 | 0.039 | 0.844 | 0.99(0.93~1.06) | TC | -0.137 | 0.096 | 2.050 | 0.152 | 0.87(0.72~1.05) |
| NIHSS评分 | TG | 0.108 | 0.065 | 2.816 | 0.093 | 1.12(0.98~1.27) | |||||
| 0~1分 | 1.00 | HDL-C | 0.026 | 0.012 | 4.929 | 0.026 | 1.03(1.00~1.05) | ||||
| 2~4分 | 0.106 | 0.270 | 0.154 | 0.695 | 1.11(0.66~1.89) | LDL-C | -0.185 | 0.119 | 2.441 | 0.118 | 0.83(0.66~1.05) |
| 5~15分 | 0.572 | 0.281 | 4.141 | 0.042 | 1.77(1.02~3.07) | HbA1c | 0.001 | 0.001 | 4.767 | 0.029 | 1.00(1.00~1.00) |
| 项目 | 模型1 | 模型2 | 模型3 | 模型4 | ||||
|---|---|---|---|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | |
| Q1亚组 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2亚组 | 1.04(0.59~1.85) | 0.883 | 1.04(0.59~1.85) | 0.887 | 1.05(0.59~1.87) | 0.861 | 0.98(0.55~1.75) | 0.941 |
| Q3亚组 | 0.77(0.42~1.43) | 0.413 | 0.75(0.41~1.40) | 0.371 | 0.75(0.41~1.39) | 0.366 | 0.75(0.41~1.40) | 0.367 |
| Q4亚组 | 1.89(1.14~3.15) | 0.014 | 1.85(1.11~3.07) | 0.018 | 1.81(1.08~3.01) | 0.023 | 1.80(1.08~3.00) | 0.024 |
| SIRI | 1.06(1.01~1.10) | 0.011 | 1.06(1.01~1.11) | 0.011 | 1.05(1.01~1.10) | 0.025 | 1.06(1.01~1.10) | 0.021 |
Table 3 Multivariate Cox regression analysis of multiple factors affecting recurrence in IS patients
| 项目 | 模型1 | 模型2 | 模型3 | 模型4 | ||||
|---|---|---|---|---|---|---|---|---|
| HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | HR(95%CI) | P值 | |
| Q1亚组 | 1.00 | 1.00 | 1.00 | 1.00 | ||||
| Q2亚组 | 1.04(0.59~1.85) | 0.883 | 1.04(0.59~1.85) | 0.887 | 1.05(0.59~1.87) | 0.861 | 0.98(0.55~1.75) | 0.941 |
| Q3亚组 | 0.77(0.42~1.43) | 0.413 | 0.75(0.41~1.40) | 0.371 | 0.75(0.41~1.39) | 0.366 | 0.75(0.41~1.40) | 0.367 |
| Q4亚组 | 1.89(1.14~3.15) | 0.014 | 1.85(1.11~3.07) | 0.018 | 1.81(1.08~3.01) | 0.023 | 1.80(1.08~3.00) | 0.024 |
| SIRI | 1.06(1.01~1.10) | 0.011 | 1.06(1.01~1.11) | 0.011 | 1.05(1.01~1.10) | 0.025 | 1.06(1.01~1.10) | 0.021 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
王陇德,彭斌,张鸿祺,等. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志,2022,19(2):136-144.
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [1] | DU Huijie, YANG Xuezhi, LIU Zuting, LIU Xingyu, ZHANG Huiqin, LUO Tian, YANG Xia, LIU Song, KUANG Jie. One-year Recurrence Risk Prediction in Large Artery Atherosclerotic Acute Ischemic Stroke Using Random Survival Forest [J]. Chinese General Practice, 2026, 29(31): 4619-4626. |
| [2] | ZHANG Panpan, ZHANG Zixin, WU Xinyu, HAN Quanle, ZHAO Li, YANG Jing, LI Lei, LI Xuyang, ZHANG Boheng, WU Shouling. A Retrospective Cohort Study on the Fatty Liver Index and Metabolic Dysfunction-associated Fatty Liver Disease in Healthy Populations [J]. Chinese General Practice, 2026, 29(31): 4582-4588. |
| [3] | ZHAN Daowei, WEI Xuwang, HU Minlei, XU Yingmei, YANG Xibing, LUO Kaitao. Effect of Acupuncture Combined with Tirofiban on Early Neurological Deterioration in Patients with Ischemic Stroke after Thrombolysis: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(29): 4241-4247. |
| [4] | LI Xiaoxue, YIN Lihua, SU Xu, ZHANG Fuyan, ZHAN Qingqing, AN Qinyu, WANG Huiqun, LIU Tao, TAN Shisheng. Association between Dietary Quality and Risk of Hypertension: a Study Based on the 2022 Version of the Chinese Dietary Balance Index [J]. Chinese General Practice, 2026, 29(25): 3631-3639. |
| [5] | DONG Ao, ZHAO Naihui, OU Wenli, CHEN Shuohua, WANG Guodong, DAI Luyao, LIU Canzhang, WU Shouling, YANG Xiuhong. Association between Cardiometabolic Index and the Incident Chronic Kidney Disease: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(25): 3614-3623. |
| [6] | ZHANG Wenzheng, ZHANG Hongling. Association between Cardiometabolic Index and Hypertension in Elderly Patients with Metabolic Associated Fatty Liver Disease in the Community Population: a Prospective Cohort Study [J]. Chinese General Practice, 2026, 29(23): 3261-3267. |
| [7] | CHAI Zhihao, ZHANG Weisen, LUO Jiaoling, ZHU Feng, ZHU Tong, JIN Yali, PAN Jing, LU Yingjun, JIANG Chaoqiang. The Mediation Effect of Socioeconomic Status in Childhood Parental Literacy and Cognitive Function in Middle-aged and Older People: Based on Guangzhou Biobank Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2959-2966. |
| [8] | HAN Congcong, QIU Xinyu, SHAN Chunfang, SONG Ning, CHEN Qingjie, MULADILI· Abudureheman, LI Xiaomei, YANG Yining, ZHAO Qian. Impact of Metabolic Obesity Phenotype on Long-term Prognosis after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome [J]. Chinese General Practice, 2026, 29(21): 2950-2958. |
| [9] | LIU Shuai, YUAN Shizhao, LIU Yan, JIA Shuoxian, ZHAO Yan, WANG Ziyi, ZHOU Chunhua, YU Jing. Evaluation of the Efficacy, Safetyand Economy of Different Amphotericin B Formulationsin Invasive Fungal Disease: a Retrospective Cohort Study [J]. Chinese General Practice, 2026, 29(21): 2967-2974. |
| [10] | REYILAI· Maimaiti, ZHOU Yiran, WU Yun, LIU Zhencheng, LU Yaoqin, WU Haiyan. Association between Novel Obesity Indicators and Cardiovascular Disease Risk in Hypertensive Patients [J]. Chinese General Practice, 2026, 29(20): 2836-2845. |
| [11] | ZHAO Huili, LU Lina, ZHUO Ya, WANG Xin. Clinical Characteristics and Risk Factors for Recurrence of Cryptogenic Organizing Pneumonia [J]. Chinese General Practice, 2026, 29(19): 2648-2655. |
| [12] | QIU Xinyu, ZHAO Qian, CHEN Yufei, JIAMULE· Maimaitiyiming, HAN Congcong, AIKEDAN· Aierken, LI Xiaomei, YANG Yining. Weight Status and Metabolic Characteristics on the Longitudinal Trajectory of Systolic Blood Pressure: a Cohort Study [J]. Chinese General Practice, 2026, 29(15): 2006-2013. |
| [13] | HAN Yue, BIAN Zhe, GU Haochen, WANG Dali, PENG Yanbo. Impact of Cumulative Defined Daily Dose of Statins on Recurrence Risk in Ischemic Stroke Patients [J]. Chinese General Practice, 2026, 29(14): 1821-1826. |
| [14] | LI Li, XU Tianchao, DONG Xiaomei, HUANG Hongfei, CUI Gang, LI Dongdong, ZHANG Ou, FAN Lin, WANG Qi. The Effect of Kidney Tonifying and Brain Strengthening Acupuncture Combined with Sertraline in the Treatment of Elderly Depression: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(11): 1399-1404. |
| [15] | LIU Yang, LIANG Fang, WU Ling, LI Wenlei, LI Pengfei. Diagnostic Value of Non-conventional Lipids and the Triglyceride-glucose Index in First-onset Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(11): 1422-1429. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||